Preventing HIV/Aids in Drug Abusing Youth

Phase 1

Completed

• Conditions: HIV Infections
• Interventions: Behavioral: IBFT /HIV prevention; Behavioral: IBFT

• Registration Number: NCT00680719
• Lead Sponsor: Oregon Research Institute

Brief Summary

This project involves two studies focusing on the engagement and treatment of adolescents diagnosed with substance use disorders. Study 1 will evaluate a promising parent-based engagement intervention, Community Reinforcement Training, designed to facilitate the entry of resistant drug-abusing adolescents in treatment. The approach will be compared with an Engagement As Usual intervention condition. Study 2 involves a controlled clinical trial evaluating the efficacy of an HIV/AIDS prevention intervention embedded in family-based drug abuse treatment for reducing HIV/AIDS risk behaviors and substance use. Adolescents who are successfully engaged in treatment through Study 1 will be randomly assigned to receive either family therapy alone or family therapy with the integrated HIV/AIDS prevention intervention. Both studies are being conducted in Portland, Oregon.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-06
• Study First Submitted: 2008-05-16
• Study First Submitted QC: 2008-05-16
• Study First Posted: 2008-05-20
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Status Verified: 2014-08
• Last Update Submitted: 2014-08-04
• Last Update Posted: 2014-08-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 111

Inclusion Criteria

• Parents have an adolescent in the ages of 15-20 years.
• Have had contact with the adolescent on at least 40% of the past 90 days.
• Have some knowledge or evidence that the adolescent would meet DSM-IV diagnostic criteria for a substance abuse disorder.
• Adolescent has explicitly refused to attend any intake or therapy sessions.
• All parents' efforts to enter adolescent into treatment have failed, despite therapist's assistance.
• Residence in Portland vicinity.
• Sufficient residential stability to permit probable contact at follow-up. (e.g. not homeless at time of intake)

Exclusion Criteria

• Evidence of psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures.
• Adolescent has received residential drug treatment longer than a 2-week period in the past 90 days.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
1	IBFT /HIV prevention	Family Therapy plus HIV prevention
2	IBFT	Family Therapy only.

Primary Outcome Measures

Name	Time	Method
Changes in adolescent's substance use.	12 months

Secondary Outcome Measures

Name	Time	Method
Changes in HIV risk behaviors.	12 months

Trial Locations

Locations (1)

Oregon Research Institute Center for Family and Adolescent Research; 🇺🇸 Portland, Oregon, United States